Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination

They say orchestras are where everyone shows up with different instruments, everyone has their own sheet music, and no one sounds quite right until the conductor brings them together. Someone’s playing too loudly. Someone else is off tempo. The strings want allegro while the brass prefers andante. And yet, when properly coordinated, something beautiful emerges.

U.S. healthcare isn’t much different, but here’s what the headlines miss: every stakeholder in healthcare’s prescription denial story, payers, providers, pharmaceutical companies, and patients, is acting completely rationally based on the information, incentives, and constraints they face. Payers aren’t denying medications to be difficult; they’re making risk-based decisions with incomplete data while managing finite resources for millions of members. Providers aren’t over-prescribing to drive profits; they’re focused on individual patient needs without visibility into broader utilization patterns or cost implications.

The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos. When prescription drug denials by private insurers jumped 25% from 2016 to 2023, affecting nearly one in four patients seeking medications, the healthcare industry focused on symptoms rather than the underlying dysfunction. When a health plan reviews a treatment request, it’s seeing diagnostic codes and costs, not the physician’s clinical reasoning or the patient’s complete journey. When doctors prescribe treatments, they’re making decisions based on individual clinical needs without understanding payer policies or alternative therapies that might be equally effective.

We’ve built a healthcare system that rewards stakeholders for optimizing their individual piece of the patient journey rather than coordinating around shared outcomes. The result is entirely predictable: rational actors making rational decisions that create irrational results. The real issue isn’t any single stakeholder behaving badly. It’s that members of our “healthcare orchestra”  can’t communicate effectively with each other.

This coordination challenge matters more than individual blame games. Healthcare brings together patients, payers, providers, pharmaceutical manufacturers, pharmacy benefit managers, employers, government agencies, and more, each with its own expectations, incentives, and desired outcomes. What benefits one group often complicates life for another. Policies that improve access can challenge profitability. Innovations in treatment may raise costs. Efficiency for one stakeholder introduces complexity for another.

In this environment, it’s not just hard to make everyone happy, it’s impossible. And that complexity creates the data fragmentation that enables problems like inappropriate prescription denials.

When payers must evaluate coverage requests without complete patient histories, when providers lack real-world effectiveness data for new treatments, when pharmaceutical companies design clinical trials without representative patient populations, the result is exactly what we’re seeing: decisions made with incomplete information that ultimately hurt patients and inflate costs.

Understanding the conductor’s challenge

Healthcare stakeholders must actively coordinate decisions that affect patient outcomes. Think of it as a complex orchestra where:

• Payers (the brass section) must balance member access with financial sustainability, making coverage decisions often without complete clinical context;
• Providers (the strings) need comprehensive patient histories to make optimal treatment recommendations, but lack visibility into cost implications and payer policies;
• Pharmaceutical companies (the woodwinds) develop treatments based on clinical trial data that may not reflect real-world patient populations and payer constraints; and
• Patients (the audience) experience the music, but often can’t hear how individual sections contribute to the overall performance.

The challenge isn’t that any section is playing poorly, it’s that they’re often playing from different sheet music.

The information gap behind rising denials

I’ve witnessed this coordination dysfunction firsthand while working with healthcare organizations across the ecosystem. Recently, I observed a payer struggling to evaluate coverage requests for a complex oncology treatment. It had basic diagnostic codes and cost information, but lacked the comprehensive patient journey data needed to understand why the prescribing physician chose this particular therapy over alternatives.

Meanwhile, the prescribing oncologist had detailed clinical rationale, but limited visibility into the payer’s medical policy requirements and prior authorization process. The pharmaceutical company had extensive clinical trial data supporting the treatment, but minimal real-world evidence about effectiveness in similar patient populations within this health plan.

Each party made reasonable decisions based on the information available to it. But without coordination, shared “sheet music”, the result was predictable; delays, denials, appeals, and frustrated patients caught in the middle.

This pattern repeats constantly. It takes healthcare organizations an average of seven months to integrate and clean data before they are able to utilize it for insight generation. During that time, patients wait, costs accumulate, and opportunities for optimal care diminish.

A balanced view of payer and provider coverage challenges

It’s important to understand the legitimate constraints payers face when making coverage decisions. Health plans manage finite resources while ensuring appropriate care for millions of members. They must:

• Evaluate treatments fairly across diverse patient populations with varying clinical needs;
• Prevent inappropriate utilization that drives up costs for all members;
• Navigate complex clinical guidelines that often lack clear real-world effectiveness data; and
• Balance innovation access with financial sustainability that keeps coverage affordable.

Similarly, when providers express frustration with prior authorization requirements or coverage denials, it’s because they operate at the level of individual patients. Clinicians see firsthand the urgency, complexity, and nuance of patient care. They must:

• Advocate for timely access to what they believe is the most effective therapy for their patient;
• Make clinical decisions based on their expertise and direct patient interactions;
• Navigate administrative hurdles that can delay care and erode patient trust; and
• Manage rising expectations from patients who are more informed and demanding personalized care.

While providers often lack visibility into the broader financial or population-level considerations payers must account for, their focus is on delivering immediate, evidence-based care. When they push back on utilization management tools, it’s not to bypass safeguards, but to ensure that real people don’t fall through the cracks of a system designed to work at scale.

Building better coordination

The solution to healthcare’s stakeholder tensions isn’t choosing sides, it’s building the infrastructure that allows all sides to work better together. That means enabling smarter information sharing while respecting the legitimate constraints of each stakeholder: clinical complexity; privacy requirements; regulatory frameworks; and business realities.

It’s not about forcing agreement, it’s about creating the conditions for meaningful coordination. It’s about focusing on cross-stakeholder insights that support better outcomes for patients, smarter risk management for payers, operational efficiency for providers, and innovation for life sciences, while safeguarding privacy and preserving competitive boundaries. A neutral arbiter of data can power a trusted platform to enable all stakeholders to work from a shared understanding (common sheet music), unlocking the collaboration required to reduce the burden of disease at scale.

Real-world success stories

Some healthcare organizations are already pioneering collaborative approaches with measurable results. Collaboration with oncology data partners, for example, can enable pharmaceutical companies to better understand real-world treatment patterns, help them design clinical trials that reflect actual patient populations and develop medical affairs strategies that support appropriate prescribing.

Partnerships such as this demonstrate what’s possible when stakeholders prioritize patient outcomes and system efficiency over information hoarding. The key is building trust through transparency about data use while ensuring all parties benefit from enhanced insights.

The path forward

Healthcare leaders should view current coordination challenges not as evidence of stakeholder conflict, but as opportunities to build collaborative capabilities needed for long-term success. Organizations that develop robust information sharing partnerships now will be better positioned to deliver coordinated care while maintaining operational efficiency.

The infrastructure supporting better coordination, standardized data formats, secure sharing protocols, and real-time synchronization can simultaneously improve clinical decision-making, streamline administrative processes, and accelerate beneficial innovation. Those that continue operating in isolation will struggle to deliver the coordinated care that patients deserve and all stakeholders ultimately want to provide.

Making beautiful music together

Just like an orchestra, the healthcare system isn’t about individual sections playing solo performances, it’s about creating harmonious outcomes that serve the broader purpose. The current system treats healthcare data as proprietary assets that must be guarded rather than coordinated resources that could benefit everyone.

In reality, comprehensive insights create value across the ecosystem: better outcomes for patients; more efficient operations for providers; improved risk assessment for payers; and more effective treatments for pharmaceutical companies.

Healthcare transformation requires recognizing that rising drug denials aren’t evidence of payer callousness or provider ignorance, they’re symptoms of coordination challenges that technology and collaboration can address. With shared information and aligned incentives, we can build a system where appropriate treatments reach patients efficiently while managing costs responsibly.

Sometimes the most beautiful music comes from orchestras where every section learns to support the others’ contributions. Healthcare is ready for that kind of performance.

Photo: pongschole1, Getty Images

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.